Clin2
NCT07624526Likely a fitNot yet recruiting

Suzetrigine to Reduce Pain and Opioid Use After Knee Surgery

Knee ArthritisKnee Osteoarthritis

Treatments studied

Part of Bones, joints & muscles clinical trials.

This study tests whether a new pain medication called suzetrigine, when combined with other pain-management strategies, can reduce pain and the need for opioids after total knee replacement surgery. The goal is to help patients recover comfortably while using fewer opioids.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
75 people
Ages
18 years to 95 years
Study type
Interventional

Who can take part

  • You are having a total knee replacement surgery for osteoarthritis (wear-and-tear of the knee joint)
  • You are between 18 and 95 years old
  • You have not been taking opioids daily in the 4 weeks before your surgery
  • You do not have serious heart, kidney, or liver problems
  • You are able to take NSAIDs (over-the-counter pain relievers like ibuprofen) without problems
  • You do not have uncontrolled diabetes, active stomach ulcers, or severe infections

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06423716Recruiting· Phase 4
Duloxetine to reduce opioid use after knee replacement

This study tests whether taking the pain medication duloxetine before and after knee replacement surgery can reduce the need for opioid painkillers. It may help patients manage pain with fewer side effects from strong narcotics.

Toronto, Ontario
NCT07231419Recruiting· Phase 3
Study of suzetrigine for diabetic nerve pain

This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.

Birmingham, Alabama
NCT06628908Recruiting· Phase 3
Study of suzetrigine for painful diabetic nerve damage

This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.

Anniston, Alabama
NCT07357376Not yet recruiting· Phase 3
Study of suzetrigine for pain after knee replacement surgery

This study tests a new pain medicine called suzetrigine for people having a first-time total knee replacement. The goal is to see if it helps control pain after surgery.

NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York

Hear when a new Knee Osteoarthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.